Scientists probe mysterious bone pain in rare disorder
NCT ID NCT07476768
First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This study aims to understand why people with fibrous dysplasia of bone or McCune-Albright syndrome experience chronic pain. Researchers will compare pain responses in 40 adults (20 patients and 20 healthy volunteers) using heat and cold tests. The goal is to see if the nervous system becomes overly sensitive, which could guide better pain treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
39 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * For patients : * Male or female over 18 years of age with fibrous dysplasia/McCune-Albright syndrome diagnosed by a rheumatologist. * Mentally and legally able to provide informed consent to participate in the study. * Affiliated with a health insurance system. * For healthy volunteers : * Male or female over 18 years of age. * Matched to patients by age and sex. * Mentally and legally able to provide informed consent to participate in the study. * Affiliated with a health insurance system. Exclusion Criteria: * For patients : * Medical and/or surgical history considered by the investigator or delegated physician to be incompatible with study procedures (e.g., amputation or physical limitation preventing completion of pain assessment tests). * Recurrent pain at sites planned for stimulation during thermal and mechanical testing (forearms or palms). * Presence of anxiety and/or depression defined as Hospital Anxiety and Depression Scale (HADS) score \>11. * Use of analgesic medication within the week preceding inclusion. * Use of complementary treatments for analgesic purposes (e.g., vitamins, herbal products, cannabinoids). * Individuals under legal protection (guardianship or trusteeship) or deprived of liberty. * Pregnant or breastfeeding women. * Refusal to participate. * For heathly volunteers : * Medical and/or surgical history considered by the investigator or delegated physician to be incompatible with study procedures (e.g., amputation or physical limitation preventing completion of pain assessment tests). * Presence of sleep disorders defined as Pittsburgh Sleep Quality Index (PSQI) score \>5. * Presence of anxiety and/or depression defined as HADS score \>11. * Use of analgesic medication within the week preceding inclusion. * Use of complementary treatments for analgesic purposes (e.g., vitamins, herbal products, cannabinoids). * Individuals under legal protection (guardianship or trusteeship) or deprived of liberty. * Pregnant or breastfeeding women. * Refusal to participate.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fibrous dysplasia of bone are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU clermont-Ferrand
Clermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.